IBEX ANNOUNCES TWO NEW DISTRIBUTOR AGREEMENTS FOR ITS GLYCOBIOLOGY ENZYMES

IBEX Technologies Inc. (TSX:IBT), a Montreal-based biopharmaceutical company, today announced that is has signed two new distribution agreements for its glycobiology enzymes. Commencing this quarter, Associates of Cape Cod Inc., a wholly owned subsidiary of Seikagaku Corporation, and Prozyme Inc. a private California based company, will begin marketing and distributing the IBEX enzymes to customers in the worldwide research community.

ArriveNet (http://press.arrivenet.com/pro/article.php/695289.html)